Nudelman ChemTox
Consulting
Contact Us
About Us
Nudelman ChemTox Consultancy specializes in impurity qualification services for pharmaceuticals, focused on ensuring safety and regulatory compliance.
We also provide computational assessments for mutagenic impurities and establish occupational exposure limits, delivering expert analysis across a range of impurity types and active pharmaceutical ingredients to ensure precise and reliable solutions that support the highest industry standards.
In addition, Nudelman ChemTox Consultancy offers hands-on training, both in person and online, to share expertise and support professional development in computational toxicology and regulatory compliance.
Raphael (Raphy) Nudelman
PhD, ERT, CEO Nudelman ChemTox Consulting
Raphael (Raphy) Nudelman is a chemical toxicologist with over 20 years of industry experience. He holds a PhD in organic chemistry from the Weizmann Institute of Science and completed postdoctoral research at the US Air Force Research Lab and Duke University Medical Center.
At Teva Pharmaceutical Industries, Raphy held various roles, including in the medicinal chemistry department, the patent department, the non-clinical safety department, and as the Impurity Expert of the company. His expertise spans impurity and excipient qualification in drug substances and drug products, with a recent focus on risk assessment of nitrosamine impurities in pharmaceuticals. Raphy retired from Teva in September 2024 and founded Nudelman ChemTox Consulting, where he continues to provide consulting services in the pharmaceutical impurity qualification field.
Alon Nudelman
PhD, VP Nudelman ChemTox Consulting
Alon Nudelman is a molecular biologist with expertise in immunology, biochemistry, and protein biology. He holds a PhD in Molecular Biology and Immunology from the Weizmann Institute of Science.
Before joining Nudelman ChemTox Consulting, he held research positions in the biotech industry, specializing in mRNA-based cancer therapeutics and nanobody biochemistry. He also has experience in occupational toxicology, focusing on impurity risk assessment and exposure limit determination.
As VP of Nudelman ChemTox Consulting, Alon contributes his expertise in pharmaceutical impurity qualification, occupational toxicology, and risk assessment strategies.
